NL8701728A - Heterocyclische verbindingen. - Google Patents

Heterocyclische verbindingen. Download PDF

Info

Publication number
NL8701728A
NL8701728A NL8701728A NL8701728A NL8701728A NL 8701728 A NL8701728 A NL 8701728A NL 8701728 A NL8701728 A NL 8701728A NL 8701728 A NL8701728 A NL 8701728A NL 8701728 A NL8701728 A NL 8701728A
Authority
NL
Netherlands
Prior art keywords
group
alkyl
general formula
hydrogen atom
compound
Prior art date
Application number
NL8701728A
Other languages
English (en)
Dutch (nl)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL8701728A publication Critical patent/NL8701728A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL8701728A 1986-07-23 1987-07-22 Heterocyclische verbindingen. NL8701728A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8617994 1986-07-23
GB868617994A GB8617994D0 (en) 1986-07-23 1986-07-23 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
NL8701728A true NL8701728A (nl) 1988-02-16

Family

ID=10601571

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8701728A NL8701728A (nl) 1986-07-23 1987-07-22 Heterocyclische verbindingen.

Country Status (8)

Country Link
JP (1) JPS6335570A (fr)
BE (1) BE1000730A5 (fr)
CH (1) CH674008A5 (fr)
DE (1) DE3724322A1 (fr)
FR (1) FR2601951B1 (fr)
GB (2) GB8617994D0 (fr)
IT (1) IT1211667B (fr)
NL (1) NL8701728A (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
CA2031214A1 (fr) 1989-04-21 1990-10-22 Alberto Azcona Utilisation therapeutique des antagonistes du recepteur 5-ht
EP1022025A3 (fr) * 1991-06-26 2002-06-05 Sepracor, Inc. Methodes et compositions pour le traitement des vomissements, de la nausee et d'autres troubles faisant appel a l'ondansetron optiquement pur R(+)
ES2043535B1 (es) * 1992-03-13 1994-08-01 Vita Invest Sa Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
CA2106642C (fr) * 1992-10-14 2005-08-16 Peter Bod Derives de carbazolone et procede d'obtention

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1182150B (it) * 1984-01-25 1987-09-30 Glaxo Group Ltd Composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmaceutiche che li contengono
EP0191562B1 (fr) * 1985-01-23 1991-07-10 Glaxo Group Limited Dérivés de tétrahydrocarbazolones
GB8518745D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process

Also Published As

Publication number Publication date
GB8617994D0 (en) 1986-08-28
GB8717353D0 (en) 1987-08-26
JPS6335570A (ja) 1988-02-16
IT1211667B (it) 1989-11-03
IT8748207A0 (it) 1987-07-22
GB2192885B (en) 1990-02-07
GB2192885A (en) 1988-01-27
FR2601951A1 (fr) 1988-01-29
BE1000730A5 (fr) 1989-03-21
DE3724322A1 (de) 1988-01-28
CH674008A5 (fr) 1990-04-30
FR2601951B1 (fr) 1991-04-26

Similar Documents

Publication Publication Date Title
EP0354777B1 (fr) Dérivés du 3-(4-pipéridine)-5-(2-sulfonylaminoéthyl)-indole
GB2208646A (en) Indole derivatives
NZ226032A (en) 2-(imidazolylmethyl)-pyrido or-azepino(4,3-b)indole-1(2h)-one derivatives; preparatory processes and pharmaceutical compositions
NL8702851A (nl) Tricyclische ketonen, werkwijzen voor de bereiding daarvan en farmaceutische composities, die zulke ketonen bevatten.
US5045545A (en) [(Imidazol-4(and 5)-yl)methyl] tetracyclic ketones having 5-HT3 antagonist activity
US9018229B2 (en) Quinolone compound and pharmaceutical composition
NO310236B1 (no) Nye 2,3-diokso-1,2,3,4-tetrahydro-quinoksalinylderivater og farmasöytisk sammensetning omfattende samme
JPH0256485A (ja) ラクタム誘導体
EP0242973A1 (fr) Dérivés de l'indole, procédé pour leur préparation et compositions pharmaceutiques les contenant
US5116984A (en) Imidazole derivatives
US4918080A (en) Imidazollyl containing ketone derivatives
EP0364274A1 (fr) Dérivés d'imidazole
NL8701728A (nl) Heterocyclische verbindingen.
US5008272A (en) Lactam derivatives
US5026696A (en) Ketone derivatives which are antagonists of 5-HT at 5-HT3 receptors, compositions containing them, and method of use
TWI552750B (zh) 作為kcnq2/3鉀離子通道調節劑之經取代之2-氧基-及2-硫基-二氫喹啉-3-羧醯胺
EP0382570B1 (fr) Dérivés de l'indole
JP5769504B2 (ja) 医薬
US5019586A (en) Ketone derivatives
KR970005300B1 (ko) 락탐 유도체
EP0345956B1 (fr) Cétones tricycliques
RU2067980C1 (ru) Производные лактама и фармацевтическая композиция, являющаяся антагонистом 5-окситраптамина /5-нт/ на 5- нт3 -рецепторах или их физиологически приемлемые соли и соловаты
NL8802906A (nl) Geneesmiddel.

Legal Events

Date Code Title Description
BV The patent application has lapsed